RadNet, Inc. (RDNT)
USD 72.41
(-5.37%)
USD 72.41
(-5.37%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 3.04 Million USD | -90.94% |
| 2022 | 33.6 Million USD | -24.17% |
| 2021 | 44.31 Million USD | 2633.96% |
| 2020 | -1.74 Million USD | -107.46% |
| 2019 | 23.44 Million USD | -27.3% |
| 2018 | 32.24 Million USD | 60735.85% |
| 2017 | 53 Thousand USD | -99.27% |
| 2016 | 7.23 Million USD | -6.21% |
| 2015 | 7.7 Million USD | 460.25% |
| 2014 | 1.37 Million USD | -35.09% |
| 2013 | 2.12 Million USD | -96.71% |
| 2012 | 64.51 Million USD | 792.23% |
| 2011 | 7.23 Million USD | 156.26% |
| 2010 | -12.85 Million USD | -466.92% |
| 2009 | -2.26 Million USD | 82.34% |
| 2008 | -12.83 Million USD | 29.2% |
| 2007 | -18.13 Million USD | -163.0% |
| 2006 | -6.89 Million USD | -119.9% |
| 2005 | -3.13 Million USD | 78.49% |
| 2004 | -14.57 Million USD | -542.96% |
| 2003 | -2.26 Million USD | 59.16% |
| 2002 | -5.55 Million USD | -138.28% |
| 2001 | 14.5 Million USD | 454.74% |
| 2000 | 2.61 Million USD | 129.04% |
| 1999 | -9 Million USD | 69.31% |
| 1998 | -29.32 Million USD | -3819.53% |
| 1997 | -748.09 Thousand USD | 91.05% |
| 1996 | -8.36 Million USD | 86.39% |
| 1995 | -61.42 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.77 Million USD | -49.41% |
| 2024 Q2 | -2.98 Million USD | -7.3% |
| 2023 FY | 3.04 Million USD | -90.94% |
| 2023 Q1 | -14.28 Million USD | -387.44% |
| 2023 Q3 | 17.54 Million USD | 109.58% |
| 2023 Q4 | -1.86 Million USD | -110.6% |
| 2023 Q2 | 8.36 Million USD | 158.59% |
| 2022 Q2 | 13.83 Million USD | 65.38% |
| 2022 Q4 | 4.96 Million USD | -22.93% |
| 2022 Q3 | 6.44 Million USD | -53.39% |
| 2022 FY | 33.6 Million USD | -24.17% |
| 2022 Q1 | 8.36 Million USD | 318.75% |
| 2021 Q4 | -3.82 Million USD | -123.57% |
| 2021 Q1 | 9.45 Million USD | 58.82% |
| 2021 Q2 | 2.87 Million USD | -69.62% |
| 2021 FY | 44.31 Million USD | 2633.96% |
| 2021 Q3 | 16.22 Million USD | 464.57% |
| 2020 Q4 | 5.95 Million USD | -3.27% |
| 2020 Q3 | 6.15 Million USD | 158.11% |
| 2020 Q2 | -10.59 Million USD | 35.24% |
| 2020 FY | -1.74 Million USD | -107.46% |
| 2020 Q1 | -16.35 Million USD | -257.33% |
| 2019 Q3 | 3.19 Million USD | -34.78% |
| 2019 Q2 | 4.89 Million USD | 231.23% |
| 2019 Q1 | -3.73 Million USD | -112.81% |
| 2019 FY | 23.44 Million USD | -27.3% |
| 2019 Q4 | 10.39 Million USD | 225.41% |
| 2018 Q4 | 29.13 Million USD | 478.21% |
| 2018 FY | 32.24 Million USD | 60735.85% |
| 2018 Q1 | -7.33 Million USD | -0.85% |
| 2018 Q2 | 5.4 Million USD | 173.67% |
| 2018 Q3 | 5.03 Million USD | -6.79% |
| 2017 Q2 | 5.31 Million USD | 538.84% |
| 2017 Q4 | -7.27 Million USD | -325.54% |
| 2017 Q3 | 3.22 Million USD | -39.25% |
| 2017 Q1 | -1.21 Million USD | -132.87% |
| 2017 FY | 53 Thousand USD | -99.27% |
| 2016 FY | 7.23 Million USD | -6.21% |
| 2016 Q1 | -1.72 Million USD | -295.57% |
| 2016 Q2 | 3.62 Million USD | 310.39% |
| 2016 Q3 | 1.64 Million USD | -54.57% |
| 2016 Q4 | 3.68 Million USD | 123.5% |
| 2015 FY | 7.7 Million USD | 460.25% |
| 2015 Q2 | 3.39 Million USD | 174.55% |
| 2015 Q3 | 7.98 Million USD | 135.26% |
| 2015 Q4 | 881 Thousand USD | -88.97% |
| 2015 Q1 | -4.55 Million USD | -208.3% |
| 2014 Q2 | 5.14 Million USD | 141.4% |
| 2014 Q1 | -12.42 Million USD | -1099.52% |
| 2014 FY | 1.37 Million USD | -35.09% |
| 2014 Q4 | 4.2 Million USD | -5.53% |
| 2014 Q3 | 4.45 Million USD | -13.47% |
| 2013 Q1 | -1.34 Million USD | -102.37% |
| 2013 FY | 2.12 Million USD | -96.71% |
| 2013 Q4 | 1.24 Million USD | 366.17% |
| 2013 Q2 | 2.68 Million USD | 300.15% |
| 2013 Q3 | -467 Thousand USD | -117.39% |
| 2012 Q4 | 56.62 Million USD | 1020.7% |
| 2012 Q1 | -111 Thousand USD | -102.44% |
| 2012 Q2 | 2.94 Million USD | 2754.05% |
| 2012 Q3 | 5.05 Million USD | 71.52% |
| 2012 FY | 64.51 Million USD | 792.23% |
| 2011 Q2 | 3.52 Million USD | 501.94% |
| 2011 FY | 7.23 Million USD | 156.26% |
| 2011 Q4 | 4.54 Million USD | 11558.97% |
| 2011 Q3 | 39 Thousand USD | -98.89% |
| 2011 Q1 | -876 Thousand USD | -126.55% |
| 2010 FY | -12.85 Million USD | -466.92% |
| 2010 Q3 | -285 Thousand USD | 97.58% |
| 2010 Q1 | -4.11 Million USD | -745.37% |
| 2010 Q2 | -11.75 Million USD | -185.96% |
| 2010 Q4 | 3.3 Million USD | 1257.89% |
| 2009 Q2 | -336 Thousand USD | 60.1% |
| 2009 FY | -2.26 Million USD | 82.34% |
| 2009 Q1 | -842 Thousand USD | 84.26% |
| 2009 Q4 | 637 Thousand USD | 136.91% |
| 2009 Q3 | -1.72 Million USD | -413.69% |
| 2008 Q2 | -2.14 Million USD | 60.75% |
| 2008 FY | -12.83 Million USD | 29.2% |
| 2008 Q3 | 138 Thousand USD | 106.42% |
| 2008 Q4 | -5.35 Million USD | -3976.81% |
| 2008 Q1 | -5.47 Million USD | 57.1% |
| 2007 Q2 | 1.32 Million USD | 130.29% |
| 2007 FY | -18.13 Million USD | -163.0% |
| 2007 Q1 | -4.37 Million USD | 0.0% |
| 2007 Q3 | -1.95 Million USD | -247.44% |
| 2007 Q4 | -12.76 Million USD | -552.79% |
| 2006 FY | -6.89 Million USD | -119.9% |
| 2006 Q2 | -1.39 Million USD | 48.35% |
| 2006 Q1 | -2.7 Million USD | -466.25% |
| 2006 Q3 | -2.32 Million USD | -66.38% |
| 2005 Q2 | -37 Thousand USD | 93.79% |
| 2005 Q4 | -477 Thousand USD | -56.91% |
| 2005 Q1 | -596 Thousand USD | 72.88% |
| 2005 FY | -3.13 Million USD | 78.49% |
| 2005 Q3 | -304 Thousand USD | -721.62% |
| 2004 Q2 | -4.51 Million USD | -138.11% |
| 2004 FY | -14.57 Million USD | -542.96% |
| 2004 Q4 | -2.19 Million USD | 67.95% |
| 2004 Q1 | -1.89 Million USD | -45.36% |
| 2004 Q3 | -6.85 Million USD | -51.8% |
| 2003 Q2 | -809 Thousand USD | -215.41% |
| 2003 Q3 | -163 Thousand USD | 79.85% |
| 2003 Q4 | -1.3 Million USD | -700.61% |
| 2003 Q1 | 701 Thousand USD | 135.12% |
| 2003 FY | -2.26 Million USD | 59.16% |
| 2002 Q3 | -2.18 Million USD | 57.4% |
| 2002 Q4 | -1.99 Million USD | 8.52% |
| 2002 FY | -5.55 Million USD | -138.28% |
| 2002 Q1 | 836 Thousand USD | -8.83% |
| 2002 Q2 | -5.12 Million USD | -712.68% |
| 2001 Q2 | 2.08 Million USD | -60.1% |
| 2001 Q4 | 917 Thousand USD | -85.4% |
| 2001 Q3 | 6.28 Million USD | 201.87% |
| 2001 Q1 | 5.21 Million USD | 465.25% |
| 2001 FY | 14.5 Million USD | 454.74% |
| 2000 Q2 | 1.13 Million USD | 61.11% |
| 2000 Q1 | 704.03 Thousand USD | 804.03% |
| 2000 FY | 2.61 Million USD | 129.04% |
| 2000 Q4 | 922.58 Thousand USD | -5.22% |
| 2000 Q3 | 973.38 Thousand USD | -14.18% |
| 1999 Q1 | -4.4 Million USD | -109.52% |
| 1999 Q3 | -1.2 Million USD | 7.69% |
| 1999 FY | -9 Million USD | 69.31% |
| 1999 Q2 | -1.3 Million USD | 70.45% |
| 1999 Q4 | -100 Thousand USD | 91.67% |
| 1998 Q3 | -23.2 Million USD | -1264.71% |
| 1998 Q2 | -1.7 Million USD | 15.0% |
| 1998 Q4 | -2.1 Million USD | 90.95% |
| 1998 FY | -29.32 Million USD | -3819.53% |
| 1998 Q1 | -2 Million USD | 16.67% |
| 1997 Q2 | -2.8 Million USD | -190.32% |
| 1997 Q3 | 6.7 Million USD | 339.29% |
| 1997 Q4 | -2.4 Million USD | -135.82% |
| 1997 FY | -748.09 Thousand USD | 91.05% |
| 1997 Q1 | 3.1 Million USD | 139.74% |
| 1996 FY | -8.36 Million USD | 86.39% |
| 1996 Q3 | -8.1 Million USD | -3950.0% |
| 1996 Q2 | -200 Thousand USD | -300.0% |
| 1996 Q1 | 100 Thousand USD | 0.0% |
| 1996 Q4 | -7.8 Million USD | 3.7% |
| 1995 FY | -61.42 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | 101.309% |
| Prenetics Global Limited | -62.72 Million USD | 104.853% |
| Star Equity Holdings, Inc. | -1.54 Million USD | 296.641% |
| CareDx, Inc | -190.28 Million USD | 101.6% |
| Exact Sciences Corporation | -204.14 Million USD | 101.491% |
| Exagen Inc. | -23.68 Million USD | 112.85% |
| Inotiv, Inc. | -105.14 Million USD | 102.895% |
| Guardant Health, Inc. | -479.44 Million USD | 100.635% |
| Biodesix, Inc. | -52.14 Million USD | 105.837% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | 215.784% |
| Precipio, Inc. | -5.85 Million USD | 152.008% |
| iSpecimen Inc. | -11.09 Million USD | 127.425% |
| Natera, Inc. | -434.8 Million USD | 100.7% |
| Aspira Women's Health Inc. | -16.69 Million USD | 118.238% |
| Standard BioTools Inc. | -74.65 Million USD | 104.077% |
| 23andMe Holding Co. | -666.7 Million USD | 100.457% |
| Castle Biosciences, Inc. | -57.46 Million USD | 105.297% |
| Personalis, Inc. | -108.29 Million USD | 102.811% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | 103.44% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | 130.602% |
| OpGen, Inc. | -32.66 Million USD | 109.318% |
| T2 Biosystems, Inc. | -50.07 Million USD | 106.079% |
| Myriad Genetics, Inc. | -112 Million USD | 102.718% |
| ICON Public Limited Company | 612.33 Million USD | 99.503% |
| NeoGenomics, Inc. | -87.96 Million USD | 103.46% |
| Star Equity Holdings, Inc. | -1.54 Million USD | 296.641% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 99.64% |
| MDxHealth SA | -43.1 Million USD | 107.063% |
| Psychemedics Corporation | -4.15 Million USD | 173.279% |
| Illumina, Inc. | -1.16 Billion USD | 100.262% |
| Check-Cap Ltd. | -17.56 Million USD | 117.327% |
| Twist Bioscience Corporation | -208.72 Million USD | 101.458% |
| DarioHealth Corp. | -59.42 Million USD | 105.122% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 101.814% |
| Sera Prognostics, Inc. | -36.24 Million USD | 108.399% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | 130.258% |
| OPKO Health, Inc. | -188.86 Million USD | 101.612% |
| Medpace Holdings, Inc. | 282.81 Million USD | 98.924% |
| Neogen Corporation | -9.42 Million USD | 132.311% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | 129.97% |
| Prenetics Global Limited | -62.72 Million USD | 104.853% |
| Mainz Biomed B.V. | -26.29 Million USD | 111.576% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | 138.352% |
| Trinity Biotech plc | -24.01 Million USD | 112.674% |
| Neuronetics, Inc. | -30.18 Million USD | 110.083% |
| Sotera Health Company | 51.37 Million USD | 94.075% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | 138.352% |